Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 12, 2007 - Issue 4
Submit an article Journal homepage
539
Views
24
CrossRef citations to date
0
Altmetric
Review

Monoclonal antibodies for prophylaxis and therapy of infectious diseases

Jan ter Meulen Executive Director Infectious Diseases, Crucell Holland BV, P.O. Box 2048, 2301, CA Leiden, The Netherlands +31 71 519 9258; +31 71 519 9800; [email protected]
, MD PhD DTM&H
Pages 525-540 | Published online: 05 Nov 2007

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mirella Luciani & Luigi Iannetti. (2017) Monoclonal antibodies and bacterial virulence. Virulence 8:6, pages 635-636.
Read now

Articles from other publishers (23)

Jonathan I. Batchelder, Patricia J. Hare & Wendy W. K. Mok. (2023) Resistance-resistant antibacterial treatment strategies. Frontiers in Antibiotics 2.
Crossref
Dapeng Li, Gregory D. Sempowski, Kevin O. Saunders, Priyamvada Acharya & Barton F. Haynes. (2022) SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment. Annual Review of Medicine 73:1, pages 1-16.
Crossref
Julie Van Lent, Jolien Breukers, Karen Ven, Louanne Ampofo, Sara Horta, Francesca Pollet, Maya Imbrechts, Nick Geukens, Karen Vanhoorelbeke, Paul Declerck & Jeroen Lammertyn. (2021) Miniaturized single-cell technologies for monoclonal antibody discovery. Lab on a Chip 21:19, pages 3627-3654.
Crossref
Patrycja Sroga, Angela Sloan, Bryce M. Warner, Kevin Tierney, Jocelyne Lew, Guodong Liu, Michael Chan, Yvon Deschambault, Derek R. Stein, Geoff Soule, Logan Banadyga, Darryl Falzarano & David Safronetz. (2021) Polyclonal alpaca antibodies protect against hantavirus pulmonary syndrome in a lethal Syrian hamster model. Scientific Reports 11:1.
Crossref
Siyu Xiu, Alexej Dick, Han Ju, Sako Mirzaie, Fatemeh Abdi, Simon Cocklin, Peng Zhan & Xinyong Liu. (2020) Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities. Journal of Medicinal Chemistry 63:21, pages 12256-12274.
Crossref
Soo Khim Chan & Theam Soon Lim. 2017. Recombinant Antibodies for Infectious Diseases. Recombinant Antibodies for Infectious Diseases 61 78 .
Gunjan Arora, Ankur Kulshreshtha, Kriti Arora, Puneet Talwar, Rishi Raj, Gurpreet Grewal, Andaleeb Sajid & Ritushree Kukreti. 2017. Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Drug Resistance in Bacteria, Fungi, Malaria, and Cancer 1 24 .
Chow Wenn Yew & Yee Joo Tan. 2016. Chikungunya Virus. Chikungunya Virus 225 233 .
Vashti Irani, Andrew J. Guy, Dean Andrew, James G. Beeson, Paul A. Ramsland & Jack S. Richards. (2015) Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases. Molecular Immunology 67:2, pages 171-182.
Crossref
Kannan TharakaramanVidya SubramanianKarthik ViswanathanSusan SloanHui-Ling YenDale L. Barnard, Y. H. Connie LeungKristy J. SzretterTyree J. KochJames C. DelaneyGregory J. BabcockGerald N. WoganRam SasisekharanZachary Shriver. (2015) A broadly neutralizing human monoclonal antibody is effective against H7N9. Proceedings of the National Academy of Sciences 112:35, pages 10890-10895.
Crossref
Friederike S. Rossmann, Diana Laverde, Andrea Kropec, Felipe Romero-Saavedra, Melanie Meyer-Buehn & Johannes Huebner. (2015) Isolation of Highly Active Monoclonal Antibodies against Multiresistant Gram-Positive Bacteria. PLOS ONE 10:2, pages e0118405.
Crossref
Bhavani V. Peddayelachagiri, Soumya Paul, Shivakiran S. Makam, Radhika M. Urs, Joseph J. Kingston, Urmil Tuteja, Murali H. Sripathy & Harsh V. Batra. (2014) Functional Characterization and Evaluation of In Vitro Protective Efficacy of Murine Monoclonal Antibodies BURK24 and BURK37 against Burkholderia pseudomallei. PLoS ONE 9:3, pages e90930.
Crossref
Vinh T. Dang, Kedar D. Mandakhalikar, Oi-Wing Ng & Yee-Joo Tan. (2013) A Simple Methodology for Conversion of Mouse Monoclonal Antibody to Human-Mouse Chimeric Form. Clinical and Developmental Immunology 2013, pages 1-6.
Crossref
Patrick J. McEnaney, Christopher G. Parker, Andrew X. Zhang & David A. Spiegel. (2012) Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human Disease. ACS Chemical Biology 7:7, pages 1139-1151.
Crossref
Shayne Cox GadNathan S. Astrof, Dan Peer & Motomu Shimaoka. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Jan ter Meulen. (2011) Monoclonal Antibodies in Infectious Diseases: Clinical Pipeline in 2011. Infectious Disease Clinics of North America 25:4, pages 789-802.
Crossref
Jody D. Berry & Ryan G. Gaudet. (2011) Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology. New Biotechnology 28:5, pages 489-501.
Crossref
Wouter Koudstaal, Fons G. UytdeHaag, Robert H. Friesen & Jaap Goudsmit. 2011. Influenza Vaccines for the Future. Influenza Vaccines for the Future 383 398 .
Ali ElBakri, Paul N. Nelson & Raed O. Abu Odeh. (2010) The state of antibody therapy. Human Immunology 71:12, pages 1243-1250.
Crossref
Michael P. Horn, Adrian W. Zuercher, Martin A. Imboden, Michael P. Rudolf, Hedvika Lazar, Hong Wu, Niels Hoiby, Stefanie C. Fas & Alois B. Lang. (2010) Preclinical In Vitro and In Vivo Characterization of the Fully Human Monoclonal IgM Antibody KBPA101 Specific for Pseudomonas aeruginosa Serotype IATS-O11 . Antimicrobial Agents and Chemotherapy 54:6, pages 2338-2344.
Crossref
Carolyn A. Saylor, Ekaterina Dadachova & Arturo Casadevall. (2010) Murine IgG1 and IgG3 Isotype Switch Variants Promote Phagocytosis of Cryptococcus neoformans through Different Receptors . The Journal of Immunology 184:1, pages 336-343.
Crossref
Carolyn Saylor, Ekaterina Dadachova & Arturo Casadevall. (2009) Monoclonal antibody-based therapies for microbial diseases. Vaccine 27, pages G38-G46.
Crossref
S.H.E. Kaufmann, A.L. Meinke & A. von Gabain. (2009) Neue Impfstoffkonzepte auf Basis moderner Erkenntnisse der ImmunologieNovel vaccination concepts on the basis of modern insights into immunology. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 52:11, pages 1069-1082.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.